The good, the bad, and the intoxicated
January 1, 2021 DOI: 10.26481/dis.20210608nm via OpenAlex
Summary
AI-generated from the abstractCannabis, the most commonly used illicit drug, alters consciousness and impairs cognitive function. In a double-blind, placebo-controlled study, 20 occasional cannabis users received acute doses of cannabis (300 μg/kg THC) or placebo in one of two dose regimes. THC increased striatal glutamate concentrations and reduced functional connectivity between the nucleus accumbens and cortical areas, indicating increased dopamine activity. These effects were dose-dependent, evident when THC serum concentrations exceeded 2 ng/ml. Changes in glutamate and functional connectivity correlated strongly, and connectivity changes correlated with subjective high and decreased attention performance. THC likely produces subjective and cognitive effects through increased striatal dopamine and loss of corticostriatal connectivity, linked to increased striatal glutamate.
Study at a glance
| Characteristics | Double-blind, placebo-controlled study |
|---|---|
| Sample size | 20 |
| Population | Occasional cannabis users |
| Dose | 300 μg/kg THC |
| Topics | Addiction Cannabis Psilocybin |
| Keywords | Psychology Consciousness Drug |
| Key finding | THC increases striatal glutamate and reduces corticostriatal functional connectivity, correlating with subjective high and impaired attention. |
Abstract
Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Rodent studies suggest that 9-tetrahydrocannabinol (THC) activates dopaminergic neurons in the limbic system, subsequently enhancing dopamine, which is implicated in the rewarding effects of cannabis. Additional evidence suggests that THC may act indirectly on dopamine firing by modulating GABA and glutamate release. This double-blind, placebo-controlled study assessed the acute influence of two doses of THC on brain kinetics of glutamate, GABA, and dopamine, in relation to behavioral outcomes, by using magnetic resonance spectroscopy and functional magnetic resonance imaging. Twenty occasional cannabis users received acute doses of cannabis (300 g/kg THC) and placebo, in one of two dose regimes (full dose and divided dose), during two separate testing days. Administration of THC increased striatal glutamate concentrations, and dopamine as indicated by a reduction in functional connectivity (FC) between the nucleus accumbens (NAc) and cortical areas. Alterations in glutamate and FC were dose dependent and evident in the full dose group where THC serum concentrations exceeded 2 ng/ml at T-max. Average glutamate changes correlated strongly with FC alterations. Additionally, THC induced changes in FC correlated with feelings of subjective high and decreased performance on an attention task. Taken together, this suggests that THC elicits subjective and cognitive alterations via increased striatal dopaminergic activity and loss of corticostriatal connectivity, which is associated with an increase in striatal glutamate.